Prolactine effect on CD69 and CD154 expression by CD4+ cells from systemic lupus erythematosus patients

Clinical and Experimental Rheumatology

Volumn 23, Issue 6, 2005, Pages 769-777

  Chavez Rueda, Karina ^a   Legorreta Haquet, Ma Victoria ^a   Cervera Castillo, Hernando ^a   Sánchez, Lourdes ^a   Jara, Luis Javier ^b   Zenteno, Edgar ^c   Blanco Favela, Francisco ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b Hospital Especialidades C M La Raza   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

CD154; CD69; Prolactine; Prolactine receptor; SLE

Indexed keywords

CD40 LIGAND; CD69 ANTIGEN; CONCANAVALIN A; HORMONE ANTIBODY; MESSENGER RNA; PRIMER RNA; PROLACTIN; PROLACTIN RECEPTOR;

ADULT; ANTIGEN EXPRESSION; ARTICLE; AUTOCRINE EFFECT; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HORMONE ACTION; HORMONE DETERMINATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPERPROLACTINEMIA; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROLACTIN RELEASE; RNA ANALYSIS; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; AUTOCRINE COMMUNICATION; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CELLS, CULTURED; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MIDDLE AGED; PROLACTIN; RECEPTORS, PROLACTIN; RNA, MESSENGER;

EID: 29944433418     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. TAN EM, COHEN AS, FRIES JF: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
2. BOMBARDIER C, GLADMAN D, UROWITZ M, CARON D, CHANG CH and the Commitee on Prognosis Studies in SLE: Derivation of the SLEDAI: A disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-40.
3. BLANCO F, KALSI J, ISENBERG DA: Analysis of antibodies to RNA in patients with systemic lupus erythematosus and other autoimmune rheumatic disease. Clin Exp Immunol 1991; 86: 66-70.
4. BLANCO F, KALSI J, RAVIRAJAN, SPEIT P, BRADWELL AR, ISENBERG DA: IgG subclasses in systemic lupus erythematosus and other rheumatic disease. Lupus 1992; 1: 391-99.
5. KELSOE G: The germinal center. A crucible for lymphocytes selection. Semin Immunol 1996; 8: 179-84.
6. DING L, GREEN JM, THOMPSON CB, SHEVACH EM: B7/CD28 dependent and independent induction of CD40 ligand expression. J Immunol 1995; 155: 5124-32.
7. GREWAL IS, FLAVELL RA: The role of CD 40 ligand in co-stimulation and T cell activation. Immunol Rev 1996; 153: 85-106.
8. TESTI R, D'AMBROSIO D, DE MARIA R, SANTONI A: The CD69 receptor: a multipurpose cell-surface trigger for haematopoietic cells. Immunol Today 1994, 15: 479-83.
9. ATZENI F, DEL PAPA N, SARZI-PUTTINI P, BERTOLAZZI F, MINONZIO F, CAPSONI F: CD69 expression on neutrophils from patients with rheumatoid arthritis. Clin Exp Rheumatol 2004; 22: 331-4.
10. GONZALEZ-AMARO R, PORTALES-PEREZ D, BARANDA L et al.: Role of IL-10 in the abnormalities of early cell activation events of lymphocytes from patients with systemic lupus erythematosus. J Autoimmun 1998; 11: 395-402.
11. CRISPIN JC, MARTINEZ A, DE PABLO P, VELASQUILLO C, ALCOCER-VARELA J: Participation of the CD69 antigen in the T-cell activation process of patients with systemic lupus erythematosus. Scand J Immunol 1998; 2: 196-200.
12. MOSZKORZOVA L, LACINOVA Z, MAREK J, MUSILOVA L, DOHNALOVA A, DOSTAL C: Hyperprolactinaemia in patients with systemic lupus erythematosus. Clin Exp Rheumatol 2002; 20: 807-12.
13. BLANCO-FAVELA F, QUINTAL-ALVAREZ G, LEAÑOS-MIRANDA A: Association between prolactin and disease activity in SLE. Influence of statistical power. J Rheumatol 1999; 26: 55-9.
14. LAVALLE C, LOYO E, PANIAGUA R: Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J Rheumatol 1987; 14: 268-72.
15. JARA LJ, GOMEZ-SANCHEZ C, SILVEIRA LH, MARTINEZ-OSUNA P, VASSEY FB, ESPINOZA LR: Hyperprolactinemia in systemic lupus erythematosus: association with disease activity. Am J Med Sci 1992; 303: 222-6.
16. BUSKILA D, LORBER M, NEUMANN L, FLUSSER D, SHOENFELD Y: No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus. J Rheumatol 1996; 23: 629-32.
17. PAUZNER R, UROWITZ MB, GLADMAN DD, COUGH J: Prolactin in systemic lupus erythematosus. J Rheumatol 1994; 21: 2064-67.
18. NEIDHART M: Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol 1996; 23: 476-81.
19. OSTENDORF B, FISCHER R, SANTEN R, SCHMITZ-LINNEWEBER B, SPECKER CH, SCHNEIDER M: Hyperprolactinemia in systemic lupus erythematosus? Scand J Rheumatol 1996; 25: 97-102.
20. BUSKILA D, BEREZIN M, GUR H et al.: Autoantibody profile in the sera of women with hyperprolactinemia. J Autoimmun 1995; 8: 415-24.
21. RUIZ-IRASTORZA G, LIMA F, ALVES J et al.: Increased rate of lupus flare during pregnancy and the puerperium: A prospective study of 78 pregnancies. Br J Rheumatol 1996; 35: 133-8.
22. FOLOMEEV M, PROKAEVA T, NASSONOVA V: Prolactin levels in men with SLE and RA. J Rheumatol 1990; 17: 1569-70.
23. MCMURRAY R, KEISLER D, KANUEKEL K, IZUI S, WALKER SE: Prolactin influences autoimmune disease activity in the female B/W mouse. J Immunol 1991; 147: 780-87.
24. McMURRAY RW, KEISLER D, IZUI S, WALKER SE: Hyperprolactinemia in male NZB/NZW (B/W) F1 mice: accelerated autoimmune disease with normal circulating testosterone. Clin Immunol Immunopathol 1994; 71: 338-43.
25. BERNTON EW, MELTZER MS, HOLADAY JW: Suppression of macrophage activation and T lymphocyte function in hypoprolactinemic mice. Science 1988; 239: 401-4
26. CLEVENGER CV, FREIER DO, KLINE JB: Prolactin receptor signal transduction in cell of the immune system. J Endocrinol 1998; 157: 187-97
27. RUSSEL DH, MATRISIAN L, KIMBLER R, LARSON DF, POULOS B, MAGUN BE: Prolactin receptor on human lymphocytes and their modulation by cyclosporine. Biochem Bioph Res Co 1984; 121: 899-906
28. CLEVENGER CV, RUSSEL DH, APPASAMY PM, PRYTOWSKY MB: Regulation of IL-2 driven T lymphocyte proliferation by prolactin. Proc Nat Acad Sciences (USA) 1990; 87: 6460-4.
29. HARTMANN DP, HOLODAY JW, BERNTON EW: Inhibition of lymphocyte proliferation by antibodies to prolactin. FASEB 1989; 3: 2194-202.
30. MATERA L, CESANO A, BELLONE G, OBERHOLTZER E: Modulatory effect of prolactin on the resting and mitogen induced activity of T, B and NK lymphocyte. Brain Behav Immun 1992; 6: 409-17.
31. LEAÑOS-MIRANDA A, PASCOE-LIRA D, CHAVEZ-RUEDA K, BLANCO-FAVELA F: Anti-prolactin antibodies in systemic ]opus erythematosus patients; Frequency and correlation with prolactinemia and disease activity J Rheumatol 2001; 7: 1546-53.
32. BLANCO-FAVELA F, QUINTAL MA G, CHAVEZ-RUEDA K et al.: Anti-prolactin autoantibodies in pediatric systemic lupus erithematosus patients. Lupus 2001; 11: 803-8.
33. TANAKA T, SHIU RPC, GOUT PW, BEER CT, NOBLE RL, FRIESEN HG: A new sensitive and specific bioassay for lactogenic hormone measurement of prolactin and growth hormone in human serum. J Clin Endocrinol Metab 1980; 51, 1058-63.
34. BERCZI I, NAGY E, KOVACS K, HORVATH E: Regulation of humoral immunity in rat by pituitary hormone. Acta endocrinol 1981; 98; 506-13.
35. DARDENNE M, LEITE DE MORALES MC, KELLY PA, GAGNERAULT MC: Prolactin receptor expression in human haematopoietic tissues analysed by flow cytofluorometry. Endocrinology 1994; 134: 2108-14.
36. RICHARDS SM, GARMA RD, KEYES L, KAVANAGH B, McPHERSONN JM: Prolactin in an antagonist of TGF-β activity and promotes proliferation of murine B cell hybridomas. Cell Immunol 1998; 184: 85-91
37. LI J, TENG W, SHAN Z: Effect of prolactin on HLA-DR and CD40 expressions by human thyrocytes. Chin Ned J 2001; 114: 1151-6
38. HORSEMAN ND, ZHAO W, MONTECINOS RODRIGUEZ E et al.: Defective Mammopoiesis, but normal haematopoiesis, in mice with a targeted disruption of the prolactine gene. EMBO 1997; 16: 6926-35.
39. CUTOLO M, CAPELLINO S, MONTAGNA P et al.: New roles for estrogens in rheumatoid arthritis. Clin Exp Rheumatol 2003; 21: 687-90.